POZ - Treatment News : Antiretrovirals Vital in Treating Cancer
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » May 2008

Special Reports

Face and Butt, Heal Thyselves

Killer Gay Sex!

Slim for Summer: Safe and Sane Weight Loss

» More

Most Talked About

HIV: Behind the Music (46)

Virtual Prevention: Fighting HIV Online (26)

Inmate Testing: Optional or Mandatory? (18)

An HIV Doc's Dilemma (11)

Senators Clinton and Obama Discuss HIV/AIDS (10)

Most Popular Lessons

Herpes Simplex Virus

Syphilis & Neurosyphilis

Shingles

The HIV Life Cycle

Human Papilloma Virus (HPV)

10 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

May 7, 2008

Antiretrovirals Vital in Treating Cancer

Antireteroviral (ARV) treatment and chemotherapy, more than any other factors, substantially increase the odds that a person with Kaposi’s sarcoma (KS)—a type of skin cancer common with HIV—will see their cancer improve and even go away, say the authors of a study published in the May 11 issue of AIDS.

Huong Nguyen, PhD, RN, from the Department of Epidemiology at the University of Washington in Seattle, and her colleagues examined the medical records of people living with HIV who were being treated at the university’s HIV clinic. They identified 64 people who were confirmed to have KS. All were men, and 31 percent had a more serious stage of KS, which when aggressive spreads to the lungs and intestines or causes ulcers and swelling.

Nguyen’s team found that approximately half of the people diagnosed with KS had complete resolution—meaning that all KS lesions disappeared—within 36 months.
When Nguyen's team looked only at improvement of KS, they found that people taking ARV treatment were four times as likely to see improvement as people not taking ARV treatment—regardless of their viral load or CD4 counts—and that people using chemotherapy were more than five times as likely to see improvement as people not using chemotherapy. When the team looked only at resolution of KS, however, only the use of ARV treatment was associated with it, again regardless of CD4 count or viral load. People taking ARV treatment were six times as likely to have resolution of their KS as people not taking ARV treatment.

Search: Kaposi's sarcoma, chemotherapy, cancer, Huong Nguyen, University of Washington


Scroll down to comment on this story.

emailrssprint

Name:

(2-50 characters)

Email:

(will not show)

City:

(optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 1 (of 1 total)    

cj, atlanta, 2008-05-07 20:20:15
This is great news. I am battling KS and currently undergoing chemo treatments. I have just started ARVs this month. I have seen great improvement since being chemo

comments 1 - 1 (of 1 total)    


[Go to top]

Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Do you suffer from allergies?
Yes
No

Monthly Poll
Question: Why are women being diagnosed so late that they have progressed to AIDS by the time of their diagnosis?
Women are too busy taking care of other family members
Doctors aren't testing
Doctors are unaware that a woman's symptoms can differ from a man's
Fear of HIV stigma
Denial
Women's lack of empowerment

Surveys
How do you see America's place in the global AIDS epidemic?

Tell us your political opinions on HIV/AIDS

more surveys  
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy